Related references
Note: Only part of the references are listed.Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors
Nancy Tripathi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Core amino acid substitutions in HCV-3a isolates from Pakistan and opportunities for multi-epitopic vaccines
Ayyaz Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
Nisha Muralidharan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study
Iruthayaraj Ancy et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
Fengxiang Song et al.
RADIOLOGY (2020)
Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
Salima Lalani et al.
VIRUSES-BASEL (2020)
Response to: Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing Quantitative Clinical Pharmacology Input to SARS-CoV-2 Therapeutics Should Be Based on Robust Data
Joseph F. Standing
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Complete Remission of Hypertrophic Discoid Cutaneous Lupus Erythematosus After Treatment of Chronic Hepatitis C With Direct-Acting Antivirals
Sumeyre Seda Ertekin et al.
JAMA DERMATOLOGY (2020)
Drug repurposing against COVID-19: focus on anticancer agents
Gennaro Ciliberto et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
In silico fight against novel coronavirus by finding chromone derivatives as inhibitor of coronavirus main proteases enzyme
Nayim Sepay et al.
STRUCTURAL CHEMISTRY (2020)
COVID-19: a fast evolving pandemic
Jimmy Whitworth
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2020)
Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds
Anh-Tien Ton et al.
MOLECULAR INFORMATICS (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
Bruno O. Villoutreix et al.
DRUG DISCOVERY TODAY (2020)
Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections
Helmut Sies et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
Yogesh Kumar et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation
Jacinta A Holmes et al.
Lancet Gastroenterology & Hepatology (2020)
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M pro enzyme through in silico approach
Arun Bahadur Gurung et al.
LIFE SCIENCES (2020)
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
Bhumi Shah et al.
LIFE SCIENCES (2020)
Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease
Emanuelle Machado Marinho et al.
MICROBIAL PATHOGENESIS (2020)
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
Alicia Jimenez-Alberto et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
Lorane Izabel da Silva Hage-Melim et al.
LIFE SCIENCES (2020)
Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences
Rohan R. Narkhede et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2020)
Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies
Ehsan Ullah Mughal et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors
Ehsan Ullah Mughal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study
Li Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis and anti-bacterial activity of a library of 1,2-benzisothiazol-3(2H)-one (BIT) derivatives amenable of crosslinking to polysaccharides
Fiorenza Viani et al.
TETRAHEDRON (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Flavonoids: promising natural compounds against viral infections
Hovakim Zakaryan et al.
ARCHIVES OF VIROLOGY (2017)
Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors
Ehsan Ullah Mughal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Flavonoids: an overview
A. N. Panche et al.
JOURNAL OF NUTRITIONAL SCIENCE (2016)
In silico ADME/T modelling for rational drug design
Yulan Wang et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2015)
A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors
A. R. King et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M-pro
Chunying Niu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Share Paper
